ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,245, issued on Sept. 29, was assigned to Palmaya PTY LTD (Subiaco, Australia).
"Treatment of inflammatory diseases of the central nervous system" was invented by Alexander George Brian O'Neil (Subiaco, Australia).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of flumazenil for the treatment of inflammatory conditions of the central nervous system, such as migraine, headache and multiple sclerosis, anxiety, PTSD, psychosis, depression, and cessation of addictive behaviours. The active may be administered in the form of an implant. The present invention also relates to the use of flumazenil, naltrexone, and opt...